emodin has been researched along with rada16-i in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, W; Huang, Y; Li, H; Liu, Y; Meng, C; Song, H; Tang, F; Wang, Y; Wei, W | 1 |
| Huang, Y; Li, D; Li, H; Tang, F; Tang, J; Wei, W; Yin, C | 1 |
2 other study(ies) available for emodin and rada16-i
| Article | Year |
|---|---|
The interaction between self - assembling peptides and emodin and the controlled release of emodin from
Topics: A549 Cells; Antineoplastic Agents; Cell Proliferation; Cell Survival; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Emodin; Hep G2 Cells; Humans; Hydrogels; Hydrophobic and Hydrophilic Interactions; Molecular Structure; Peptides; Suspensions | 2019 |
Antitumor Effects of Self-Assembling Peptide-Emodin in situ Hydrogels in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Emodin; Endocytosis; Erythrocytes; Hemolysis; Humans; Hydrogels; Hydrophobic and Hydrophilic Interactions; Materials Testing; Mice, Inbred C57BL; Neoplasm Invasiveness; Peptides; Rabbits; Suspensions; Xenograft Model Antitumor Assays | 2021 |